{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:14:34Z","timestamp":1787764474919,"version":"build-2784847793"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antineutrophil cytoplasmic antibody (ANCA)\u2013associated vasculitis (AAV) is a group of autoimmune disorders that cause inflammation and necrosis of small- to medium-sized blood vessels. It most commonly affects the kidneys and lungs, leading to complications such as rapidly progressive glomerulonephritis and pulmonary haemorrhage. Ocular involvement occurs in up to 50% of patients with AAV, most commonly presenting as scleritis, episcleritis, or orbital inflammatory disease (also known as orbital pseudotumor). Other ocular findings may include keratitis, uveitis, or retinal vasculitis. Eyelid necrosis with destructive orbital inflammation, however, is extremely rare and poses a significant diagnostic challenge because its presentation can mimic infections, malignancies, or other inflammatory orbital conditions. Prompt recognition is critical to prevent irreversible tissue damage and vision loss. We report the case of a 74-year-old Hispanic woman with multiple vascular risk factors who presented with recurrent pustules of the right upper eyelid that progressed to full-thickness eyelid necrosis, medial orbital mass effect, and corneal compromise. Initial management was directed toward presumed orbital cellulitis; however, orbital imaging revealed a destructive extraconal mass with mass effect and associated venous stasis. Sequential biopsies demonstrated extensive necrosis with histiocytoid granulomatous inflammation and focal features of chronic vasculitis. Negative stains and cultures excluded infectious and neoplastic causes. After thorough evaluation and exclusion of alternative etiologies, the findings were most consistent with ANCA-negative ANCA\u2013AAV. The patient was treated with high-dose intravenous corticosteroids and rituximab induction, resulting in stabilization of orbital disease and preservation of vision. This case highlights the potential for destructive orbital vasculitis to masquerade as infection or malignancy and underscores the importance of considering AAV in atypical orbital presentations. Prompt recognition and initiation of immunosuppressive therapy are critical to prevent irreversible morbidity.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag045","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:21:29Z","timestamp":1782127289000},"source":"Crossref","is-referenced-by-count":1,"title":["Organ-limited ANCA-associated orbital inflammatory disease: a diagnostic challenge"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0438-5635","authenticated-orcid":false,"given":"Aron M","family":"Sebhat","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Arizona College of Medicine - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam G","family":"Hidad","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine , Washington, DC, 20057 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Arizona College of Medicine - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Da Silva","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Howard University Medical Center , Washington, DC, 20059 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamim","family":"Sultani","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Arizona College of Medicine - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Arizona College of Medicine - Tucson , Tucson, AZ, 85724 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Stagner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School , Boston, MA, 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Banner University Medical Center - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Keshavamurthy","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Banner University Medical Center - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]},{"name":"Department of Rheumatology, University of Arizona College of Medicine - Phoenix , Phoenix, AZ, 85004 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2026070816232824800_ref1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5858\/arpa.2016-0098-RA","article-title":"Pathology of antineutrophil cytoplasmic antibody\u2013associated pulmonary and renal disease","volume":"141","author":"Smith","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"2026070816232824800_ref2","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/rheumatology\/keac663","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"62","author":"Junek","year":"2023","journal-title":"Rheumatology"},{"key":"2026070816232824800_ref3","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s10067-024-07034-y","article-title":"Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers","volume":"43","author":"Liu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"2026070816232824800_ref4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.eye.6702383","article-title":"Orbital inflammatory disease: a diagnostic and therapeutic challenge","volume":"20","author":"Gordon","year":"2006","journal-title":"Eye"},{"key":"2026070816232824800_ref5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/rheumatology\/kex261","article-title":"Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study","volume":"56","author":"Ungprasert","year":"2017","journal-title":"Rheumatology"},{"key":"2026070816232824800_ref6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"2026070816232824800_ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12886-022-02743-x","article-title":"The eye is a common site of granulomatosis with polyangiitis. A collaborative study","volume":"23","author":"Dammacco","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"2026070816232824800_ref8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.46497\/ArchRheumatol.2020.7503","article-title":"Rare presentation of severely limited granulomatosis with polyangiitis manifesting with orbital wall destruction: literature review and case report","volume":"35","author":"Havuz","year":"2020","journal-title":"Arch Rheumatol"},{"key":"2026070816232824800_ref9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2026070816232824800_ref10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2020.06.015","article-title":"Lymphoma of the lacrimal gland \u2014 an international multicenter retrospective study","volume":"219","author":"Vest","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"2026070816232824800_ref11","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/412896","article-title":"Orbital IgG4-related disease: clinical features and diagnosis","volume":"2012","author":"Kubota","year":"2012","journal-title":"ISRN Rheumatol"},{"key":"2026070816232824800_ref12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000535235","article-title":"Idiopathic granulomatous orbital inflammation with right frontal nerve involvement: a case report","author":"Pietris","year":"2023","journal-title":"Case Rep Ophthalmol"},{"key":"2026070816232824800_ref13","first-page":"684","article-title":"Histopathological features predictive of a clinical diagnosis of ophthalmic granulomatosis with polyangiitis (GPA)","volume":"5","author":"Isa","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"2026070816232824800_ref14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5633\/amm.2023.0315","article-title":"Immunoglobulin G4 (IGG4) related disease and granulomatosis with polyangiitis (GPA) in childhood: a CASE report of new overlap syndrome","volume":"62","author":"Manojlovi\u0107","year":"2023","journal-title":"Acta Medica Median"},{"key":"2026070816232824800_ref15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/rheumatology\/kez071","article-title":"Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients","volume":"58","author":"Durel","year":"2019","journal-title":"Rheumatology"},{"key":"2026070816232824800_ref16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5152\/eurjrheum.2024.24029","article-title":"Orbital masses in granulomatosis with polyangiitis: a call for clinical vigilance","volume":"11","author":"Fonseca Silva","year":"2024","journal-title":"Eur J Rheumatol"},{"key":"2026070816232824800_ref17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yexmp.2015.07.002","article-title":"Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling","volume":"99","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"2026070816232824800_ref18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.41986","article-title":"2022 American College of Rheumatology\/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis","volume":"74","author":"Robson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026070816232824800_ref19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40123-019-0176-8","article-title":"Ocular manifestations of granulomatosis with polyangiitis: a review of the literature","volume":"8","author":"Sfiniadaki","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"2026070816232824800_ref20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4329\/wjr.v6.i4.106","article-title":"Orbital inflammatory disease: pictorial review and differential diagnosis","volume":"6","author":"Pakdaman","year":"2014","journal-title":"World J Radiol"},{"key":"2026070816232824800_ref21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.5858\/arpa.2013-0006-RS","article-title":"Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings","volume":"138","author":"Muller","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"2026070816232824800_ref22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41584-025-01266-1","article-title":"Advances in the treatment of ANCA-associated vasculitis","volume":"21","author":"Trivioli","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"2026070816232824800_ref23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jcjo.2019.05.004","article-title":"Clinical and histopathological findings of patients with orbital granulomatosis with polyangiitis cases refractory to rituximab","volume":"54","author":"Starr","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"2026070816232824800_ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0000000000000020","article-title":"Granulomatosis with polyangiitis (Wegener\u2019s): impact of maintenance therapy duration","volume":"93","author":"Springer","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2026070816232824800_ref25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jamaophthalmol.2013.8179","article-title":"Rituximab therapy for refractory orbital inflammation: results of a phase 1\/2, dose-ranging, randomized clinical trial","volume":"132","author":"Suhler","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2026070816232824800_ref26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/kes382","article-title":"Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage","volume":"52","author":"Holle","year":"2013","journal-title":"Rheumatology"},{"key":"2026070816232824800_ref27","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.18240\/ijo.2024.12.07","article-title":"Guidelines for the standardized diagnosis and treatment of non-specific orbital inflammation (2024)","volume":"17","author":"Shao","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"2026070816232824800_ref28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajoc.2018.03.014","article-title":"Successful reconstruction of an ocular defect resulting from granulomatosis with polyangiitis, following treatment with rituximab","volume":"10","author":"Kenny","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2026070816232824800_ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/EB.S180190","article-title":"Orbital apex syndrome: a review","volume":"11","author":"Badakere","year":"2019","journal-title":"Eye Brain"},{"key":"2026070816232824800_ref30","doi-asserted-by":"crossref","first-page":"1112899","DOI":"10.3389\/fimmu.2023.1112899","article-title":"Unmet needs in ANCA-associated vasculitis: physicians\u2019 and patients\u2019 perspectives","volume":"14","author":"Quartuccio","year":"2023","journal-title":"Front Immunol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag045\/68586438\/rxag045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag045\/68586438\/rxag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag045\/68586438\/rxag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:23:34Z","timestamp":1783542214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag045\/8714130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag045","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag045"}}